vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and 3D SYSTEMS CORP (DDD). Click either name above to swap in a different company.

3D SYSTEMS CORP is the larger business by last-quarter revenue ($106.3M vs $62.1M, roughly 1.7× Cytek Biosciences, Inc.). 3D SYSTEMS CORP runs the higher net margin — -18.4% vs -70.9%, a 52.6% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -4.3%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-16.6M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 1.6%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

3D Systems Corporation is an American company based in Rock Hill, South Carolina, that engineers, manufactures, and sells 3D printers, 3D printing materials, 3D printed parts, and application engineering services. The company creates product concept models, precision and functional prototypes, master patterns for tooling, as well as production parts for direct digital manufacturing. It uses proprietary processes to fabricate physical objects using input from computer-aided design and manufact...

CTKB vs DDD — Head-to-Head

Bigger by revenue
DDD
DDD
1.7× larger
DDD
$106.3M
$62.1M
CTKB
Growing faster (revenue YoY)
CTKB
CTKB
+12.4% gap
CTKB
8.1%
-4.3%
DDD
Higher net margin
DDD
DDD
52.6% more per $
DDD
-18.4%
-70.9%
CTKB
More free cash flow
CTKB
CTKB
$14.9M more FCF
CTKB
$-1.8M
$-16.6M
DDD
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
1.6%
DDD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
DDD
DDD
Revenue
$62.1M
$106.3M
Net Profit
$-44.1M
$-19.5M
Gross Margin
52.9%
30.8%
Operating Margin
-9.0%
-21.3%
Net Margin
-70.9%
-18.4%
Revenue YoY
8.1%
-4.3%
Net Profit YoY
-557.1%
41.7%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
DDD
DDD
Q4 25
$62.1M
$106.3M
Q3 25
$52.3M
$91.2M
Q2 25
$45.6M
$94.8M
Q1 25
$41.5M
$94.5M
Q4 24
$57.5M
$111.0M
Q3 24
$51.5M
$112.9M
Q2 24
$46.6M
$113.3M
Q1 24
$44.9M
$102.9M
Net Profit
CTKB
CTKB
DDD
DDD
Q4 25
$-44.1M
$-19.5M
Q3 25
$-5.5M
$-18.1M
Q2 25
$-5.6M
$104.4M
Q1 25
$-11.4M
$-37.0M
Q4 24
$9.6M
$-33.5M
Q3 24
$941.0K
$-178.6M
Q2 24
$-10.4M
$-27.3M
Q1 24
$-6.2M
$-16.0M
Gross Margin
CTKB
CTKB
DDD
DDD
Q4 25
52.9%
30.8%
Q3 25
52.7%
32.3%
Q2 25
52.3%
38.1%
Q1 25
48.6%
34.6%
Q4 24
58.5%
31.0%
Q3 24
56.3%
36.9%
Q2 24
54.6%
41.6%
Q1 24
51.3%
39.8%
Operating Margin
CTKB
CTKB
DDD
DDD
Q4 25
-9.0%
-21.3%
Q3 25
-17.6%
-23.4%
Q2 25
-23.3%
-16.2%
Q1 25
-36.1%
-38.9%
Q4 24
5.2%
-27.4%
Q3 24
-8.2%
-160.0%
Q2 24
-18.3%
-23.3%
Q1 24
-23.9%
-38.7%
Net Margin
CTKB
CTKB
DDD
DDD
Q4 25
-70.9%
-18.4%
Q3 25
-10.5%
-19.8%
Q2 25
-12.2%
110.1%
Q1 25
-27.5%
-39.1%
Q4 24
16.8%
-30.1%
Q3 24
1.8%
-158.2%
Q2 24
-22.4%
-24.1%
Q1 24
-13.8%
-15.5%
EPS (diluted)
CTKB
CTKB
DDD
DDD
Q4 25
$0.04
Q3 25
$-0.14
Q2 25
$0.57
Q1 25
$-0.28
Q4 24
$-0.26
Q3 24
$-1.35
Q2 24
$-0.21
Q1 24
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
DDD
DDD
Cash + ST InvestmentsLiquidity on hand
$90.9M
$95.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$240.4M
Total Assets
$461.5M
$521.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
DDD
DDD
Q4 25
$90.9M
$95.6M
Q3 25
$93.3M
$95.5M
Q2 25
$75.5M
$116.4M
Q1 25
$95.3M
$135.0M
Q4 24
$98.7M
$171.3M
Q3 24
$162.3M
$190.0M
Q2 24
$177.9M
$192.7M
Q1 24
$168.8M
$212.0M
Stockholders' Equity
CTKB
CTKB
DDD
DDD
Q4 25
$341.7M
$240.4M
Q3 25
$378.6M
$221.1M
Q2 25
$377.6M
$241.2M
Q1 25
$379.6M
$145.6M
Q4 24
$395.7M
$176.2M
Q3 24
$385.5M
$218.0M
Q2 24
$389.1M
$381.7M
Q1 24
$392.6M
$408.4M
Total Assets
CTKB
CTKB
DDD
DDD
Q4 25
$461.5M
$521.7M
Q3 25
$494.9M
$554.5M
Q2 25
$493.3M
$587.8M
Q1 25
$482.6M
$583.4M
Q4 24
$499.5M
$608.8M
Q3 24
$491.2M
$658.3M
Q2 24
$483.7M
$821.5M
Q1 24
$492.1M
$857.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
DDD
DDD
Operating Cash FlowLast quarter
$-771.0K
$-14.7M
Free Cash FlowOCF − Capex
$-1.8M
$-16.6M
FCF MarginFCF / Revenue
-2.9%
-15.7%
Capex IntensityCapex / Revenue
1.6%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$-97.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
DDD
DDD
Q4 25
$-771.0K
$-14.7M
Q3 25
$-3.9M
$-13.5M
Q2 25
$108.0K
$-25.8M
Q1 25
$-125.0K
$-33.8M
Q4 24
$2.0M
$-7.8M
Q3 24
$13.2M
$-801.0K
Q2 24
$6.2M
$-10.8M
Q1 24
$4.0M
$-25.5M
Free Cash Flow
CTKB
CTKB
DDD
DDD
Q4 25
$-1.8M
$-16.6M
Q3 25
$-4.6M
$-15.8M
Q2 25
$-1.5M
$-28.8M
Q1 25
$-974.0K
$-36.6M
Q4 24
$1.1M
$-13.1M
Q3 24
$12.2M
$-4.4M
Q2 24
$5.2M
$-14.7M
Q1 24
$3.4M
$-28.7M
FCF Margin
CTKB
CTKB
DDD
DDD
Q4 25
-2.9%
-15.7%
Q3 25
-8.7%
-17.3%
Q2 25
-3.2%
-30.4%
Q1 25
-2.3%
-38.7%
Q4 24
1.9%
-11.8%
Q3 24
23.7%
-3.9%
Q2 24
11.0%
-13.0%
Q1 24
7.6%
-27.9%
Capex Intensity
CTKB
CTKB
DDD
DDD
Q4 25
1.6%
1.8%
Q3 25
1.3%
2.5%
Q2 25
3.5%
3.1%
Q1 25
2.0%
3.0%
Q4 24
1.6%
4.8%
Q3 24
2.0%
3.2%
Q2 24
2.3%
3.5%
Q1 24
1.3%
3.1%
Cash Conversion
CTKB
CTKB
DDD
DDD
Q4 25
Q3 25
Q2 25
-0.25×
Q1 25
Q4 24
0.21×
Q3 24
14.05×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

DDD
DDD

Products$62.6M59%
Services$43.7M41%

Related Comparisons